Navigation Links
Breakthrough In Prostate Cancer Detection And Treatment

In a research conducted in the US, scientists have claimed that a new blood test they have now found could change the way the disease of prostate cancer is diagnosed and// treated.

Researchers hoping that the test will be available to patients in 18 months, have explained that not only is the test more accurate than the standard PSA test, but it might also be able to identify the cancers that have begun to spread.

Researchers had explained that for many years the levels of Protein specific antigen or PSA could be calculated in a test had been considered as the most reliable primary indicator of prostate cancer. But there did exist a problem with the test as many a times it was found that there were some patients with abnormal levels who were cancer-free, while others have cancers but it was missed as the readings were very low. PSA is a protein that is released into the blood by prostate cells.

It was reported that the Johns Hopkins Medical Institutions in Baltimore, Maryland, US, have developed the new test. It was explained that the test now looks for a different protein called early prostate cancer antigen-2, or EPCA-2. The researchers further explained that patients with an EPCA-2 cut-off level of 30 monograms per millilitre (ngml) of blood or higher are thought to be at risk of acquiring prostate cancer.

The researchers had explained that they conducted their study of tests on 330 patients, which even included some who had prostate cancer, and that the came up with the result of the test showing a negative result for 97% of patients who did not have the disease. They also explained that the EPCA-2 levels at or above the cut-off point were found in 90% of men with cancer that was restricted to the prostate, and 98% of those with cancer that had begun its spread away from the gland.

It was explained that on the overall, the test was successful in identifying prostate cancer patients with an accuracy of 94%, in comparison with the old PSA levels of between four and 10 ngml that were detected in only 85% of patients with prostate cancer.
'"/>




Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Breakthrough in eye treatment
4. Genetic Breakthrough in Common Eye Problem
5. Breakthrough in cancer therapy
6. Breakthrough in Type II Diabetes
7. Breakthrough In Stem Cell Work
8. A Likely Breakthrough For Prostate Cancer Patients
9. New DNA Breakthrough Can Change Future Of Medicine
10. Breakthrough In New Vaccine For Malaria
11. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... ... The StayWell Company and VUCA Health announced today that ... behavior change and improve health literacy among patients. VUCA Health, which created and manages ... video capability at StayWell booth 3443 during HiMSS. , The VUCA library has ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... to stop by for a visit this week at HIMSS 2017 Conference & ... from around the globe. Sensogram will be featured in the conference’s Connected Health ...
(Date:2/20/2017)... NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software Company, ... growth of the company. The new location will triple the size of the previous ... for the town of Sunapee, NH. , “We are excited to expand our ...
(Date:2/20/2017)... Petersburg, Fla. (PRWEB) , ... February 20, 2017 , ... ... its research and education building. A topping out ceremony on Friday marked the halfway ... The building, set to open in Fall 2018, will serve as a center for ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... providers and health plan partners, announced during the 2017 Annual HIMSS Conference ... care coordination for diabetic patients and integrating eye care into mainstream healthcare ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... SAN FRANCISCO , February 20, 2017 /PRNewswire/ ... (CSF) management market  is anticipated to reach USD ... report by Grand View Research, Inc. Constant evaluation ... hydrocephalus management is expected to drive growth in ... the investment for development of novel and improved ...
(Date:2/20/2017)... Chronic and Prophylaxis GVHD The global graft versus host disease ... and CAGR of 3% from 2021-2027. The market is expected to grow ... estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in 2026. ... How this report will benefit ... business opportunities emerging in this sector. In this brand new 162-page ...
(Date:2/19/2017)... British Columbia , February 18, 2017 ... into an agreement to purchase a Medical Delivery Service ... or coordinate cannabis transactions between qualified patients and caregivers. ... Mirage , located in the Coachella Valley, ... Greater Los Angeles area to ...
Breaking Medicine Technology: